(CIVI) Civitas Resources - Overview
Stock: Crude, Natural Gas, Liquids
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 6.40% |
| Yield on Cost 5y | 13.65% |
| Yield CAGR 5y | 14.52% |
| Payout Consistency | 75.1% |
| Payout Ratio | 29.3% |
| Risk 5d forecast | |
|---|---|
| Volatility | 42.0% |
| Relative Tail Risk | -0.74% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -0.63 |
| Alpha | -70.65 |
| Character TTM | |
|---|---|
| Beta | 1.915 |
| Beta Downside | 2.456 |
| Drawdowns 3y | |
|---|---|
| Max DD | 67.18% |
| CAGR/Max DD | -0.26 |
Description: CIVI Civitas Resources January 12, 2026
Civitas Resources, Inc. (NYSE:CIVI) is an upstream oil and gas producer that concentrates on acquiring, developing, and operating crude-oil-rich and liquids-rich natural-gas assets. Its portfolio comprises roughly 356,800 net acres in Colorado’s Denver-Julesburg (DJ) Basin and about 120,400 net acres across the Permian Basin in Texas and New Mexico. The company, formerly Bonanza Creek Energy, was incorporated in 2010 and is headquartered in Denver, Colorado.
Based on its most recent 2023 Form 10-K, Civitas generated approximately 2,400 boe/d of net production, with a 2023 cash flow conversion of ~1.2 × and a debt-to-EBITDA ratio of 2.5 ×, indicating moderate leverage for a small-cap E&P. The DJ Basin’s proximity to existing pipeline infrastructure and the Permian’s high-grade liquids-rich sweet gas provide a cost-advantage in a market where oil prices above $80 /barrel and natural-gas differentials above $2.50/MMBtu have historically driven margin expansion. A key sector driver is the ongoing U.S. shale-oil output rebound, reflected in a 6 % YoY increase in rig count across the Permian in Q4 2023, which supports higher field-level efficiencies and capital-expenditure discipline.
For a deeper, data-rich view of CIVI’s valuation dynamics, you may find ValueRay’s analytical dashboard worth a look.
Piotroski VR‑10 (Strict, 0-10) 6.0
| Net Income: 638.1m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.06 > 0.02 and ΔFCF/TA 2.65 > 1.0 |
| NWC/Revenue: -15.94% < 20% (prev -22.92%; Δ 6.98% < -1%) |
| CFO/TA 0.18 > 3% & CFO 2.74b > Net Income 638.1m |
| Net Debt (5.08b) to EBITDA (3.26b): 1.56 < 3 |
| Current Ratio: 0.56 > 1.5 & < 3 |
| Outstanding Shares: last quarter (89.0m) vs 12m ago -9.43% < -2% |
| Gross Margin: 43.88% > 18% (prev 0.43%; Δ 4345 % > 0.5%) |
| Asset Turnover: 31.25% > 50% (prev 33.56%; Δ -2.32% > 0%) |
| Interest Coverage Ratio: 2.80 > 6 (EBITDA TTM 3.26b / Interest Expense TTM 454.9m) |
Altman Z'' 0.94
| A: -0.05 (Total Current Assets 945.0m - Total Current Liabilities 1.70b) / Total Assets 15.11b |
| B: 0.14 (Retained Earnings 2.04b / Total Assets 15.11b) |
| C: 0.08 (EBIT TTM 1.27b / Avg Total Assets 15.06b) |
| D: 0.24 (Book Value of Equity 2.05b / Total Liabilities 8.43b) |
| Altman-Z'' Score: 0.94 = BB |
Beneish M -3.35
| DSRI: 0.75 (Receivables 523.0m/750.3m, Revenue 4.71b/5.04b) |
| GMI: 0.99 (GM 43.88% / 43.41%) |
| AQI: 1.14 (AQ_t 0.01 / AQ_t-1 0.01) |
| SGI: 0.93 (Revenue 4.71b / 5.04b) |
| TATA: -0.14 (NI 638.1m - CFO 2.74b) / TA 15.11b) |
| Beneish M-Score: -3.35 (Cap -4..+1) = AA |
What is the price of CIVI shares?
Over the past week, the price has changed by +1.22%, over one month by +0.48%, over three months by -3.01% and over the past year by -43.43%.
Is CIVI a buy, sell or hold?
- StrongBuy: 5
- Buy: 2
- Hold: 8
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the CIVI price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 36.2 | 32% |
| Analysts Target Price | 36.2 | 32% |
| ValueRay Target Price | 28.3 | 3.3% |
CIVI Fundamental Data Overview January 26, 2026
P/E Forward = 6.3573
P/S = 0.4898
P/B = 0.3452
P/EG = 2.1193
Revenue TTM = 4.71b USD
EBIT TTM = 1.27b USD
EBITDA TTM = 3.26b USD
Long Term Debt = 5.14b USD (from longTermDebt, last quarter)
Short Term Debt = 50.6m USD (from shortTermDebt, last fiscal year)
Debt = 5.14b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 5.08b USD (from netDebt column, last quarter)
Enterprise Value = 7.39b USD (2.31b + Debt 5.14b - CCE 56.0m)
Interest Coverage Ratio = 2.80 (Ebit TTM 1.27b / Interest Expense TTM 454.9m)
EV/FCF = 7.92x (Enterprise Value 7.39b / FCF TTM 933.7m)
FCF Yield = 12.63% (FCF TTM 933.7m / Enterprise Value 7.39b)
FCF Margin = 19.84% (FCF TTM 933.7m / Revenue TTM 4.71b)
Net Margin = 13.56% (Net Income TTM 638.1m / Revenue TTM 4.71b)
Gross Margin = 43.88% ((Revenue TTM 4.71b - Cost of Revenue TTM 2.64b) / Revenue TTM)
Gross Margin QoQ = 70.89% (prev 28.46%)
Tobins Q-Ratio = 0.49 (Enterprise Value 7.39b / Total Assets 15.11b)
Interest Expense / Debt = 2.34% (Interest Expense 120.0m / Debt 5.14b)
Taxrate = 24.36% (57.0m / 234.0m)
NOPAT = 962.0m (EBIT 1.27b * (1 - 24.36%))
Current Ratio = 0.56 (Total Current Assets 945.0m / Total Current Liabilities 1.70b)
Debt / Equity = 0.77 (Debt 5.14b / totalStockholderEquity, last quarter 6.68b)
Debt / EBITDA = 1.56 (Net Debt 5.08b / EBITDA 3.26b)
Debt / FCF = 5.44 (Net Debt 5.08b / FCF TTM 933.7m)
Total Stockholder Equity = 6.70b (last 4 quarters mean from totalStockholderEquity)
RoA = 4.24% (Net Income 638.1m / Total Assets 15.11b)
RoE = 9.52% (Net Income TTM 638.1m / Total Stockholder Equity 6.70b)
RoCE = 10.74% (EBIT 1.27b / Capital Employed (Equity 6.70b + L.T.Debt 5.14b))
RoIC = 8.20% (NOPAT 962.0m / Invested Capital 11.73b)
WACC = 5.24% (E(2.31b)/V(7.45b) * Re(12.97%) + D(5.14b)/V(7.45b) * Rd(2.34%) * (1-Tc(0.24)))
Discount Rate = 12.97% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -33.33 | Cagr: -2.98%
[DCF Debug] Terminal Value 80.82% ; FCFF base≈771.9m ; Y1≈506.7m ; Y5≈231.2m
Fair Price DCF = 26.77 (EV 7.37b - Net Debt 5.08b = Equity 2.28b / Shares 85.3m; r=5.90% [WACC]; 5y FCF grow -40.0% → 2.90% )
[DCF Warning] FCF declining rapidly (-40.0%), DCF may be unreliable
EPS Correlation: -72.16 | EPS CAGR: -49.31% | SUE: -3.13 | # QB: 0
Revenue Correlation: 65.43 | Revenue CAGR: 24.70% | SUE: -0.29 | # QB: 0
EPS next Quarter (2026-03-31): EPS=1.23 | Chg30d=-0.024 | Revisions Net=-2 | Analysts=8
EPS next Year (2026-12-31): EPS=4.76 | Chg30d=-0.056 | Revisions Net=-4 | Growth EPS=-22.2% | Growth Revenue=-6.9%